Advertisement
Podcast

Reclassifying Schizophrenia

09/17/2019

Robert S. Laitman, MD, discusses evidence supporting the reclassification of schizophrenia as a neurological disorder, his views on how reclassification could impact prognosis and recovery, and treatment interventions he says have led to meaningful recovery in his patients with schizophrenia.

Robert S. Laitman, MD, is an internal medicine physician at Bronx Westchester Medical Group in New York. He is on the Board of Directors for the Schizophrenia and Related Disorders Alliance of America, and is also a board member of the National Alliance of Mental Illness - New York. Over the last 10 years, he has developed a practice taking care of people with psychotic disorders after his son, Daniel, received a diagnosis of schizophrenia in 2006.

 

Published in partnership with  SARDAA

References and Additional Reading:

Amador X. I Am Not Sick, I Don't Need Help! How to Help Someone with Mental Illness Accept Treatment. 10th anniversary ed. Peconic, NY: Vida Press. 2011.

Amminger GP, Schäfer MR, Schlögelhofer M, Klier CM, McGorry PD. Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study. Nat Commun. 2015;6:7934. doi:10.1038/ncomms8934.

Freedman R, Ross RG. Prenatal choline and the development of schizophrenia. Shanghai Arch Psychiatry. 2015;27(2):90-102. doi:10.11919/j.issn.1002-0829.215006.

Fuller Torrey E. Surviving Schizophrenia: A Family Manual. 7th ed. New York, NY: Harper Perennial. 2019.

Gardner KN, Nasrallah HA. Managing first-episode psychosis: an early stage of schizophrenia with distinct treatment needs: minimize duration of untreated psychosis; aim for remission. Current Psychiatry. 2015;14(5).

Kalmady SV, Agrawal R, Venugopal D, et al. CHRFAM7A gene expression in schizophrenia: clinical correlates and the effect of antipsychotic treatment. J Neural Transm (Vienna). 2018;125(4):741-748. doi: 0.1007/s00702-017-1833-5.

Meyer JM, Stahl SM. The Clozapine Handbook. Cambridge, UK: Cambridge University Press. 2019.

Opler LA, Laitman RS, Mandel Laitman A, Laitman D. Meaningful Recovery from Schizophrenia and Serious Mental Illness with Clozapine. Scotts Valley, CA: CreateSpace Independent Publishing Platform. 2017.

Related Content

NAFLD
NAFLD
Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD
07/15/2020
He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
07/15/2020
Pain Management
Pain Management
Ronald Martin on a Harm Reduction Model for Combatting the Opioid Crisis
05/20/2019
Ronald Martin, from the North Carolina Harm Reduction Coalition, explains what a harm reduction model is, how to implement it, and how this model can combat the opioid crisis.
05/20/2019
Cardiometabolic Risk
Cardiometabolic Risk
Michael Ozner, MD, on Cardiometabolic Health: Adhering to the Mediterranean Diet, Part 1
08/04/2017
<p>Dr. Michael Ozner, renowned cardiologist and author, discusses what the Mediterranean diet is and how it brings health benefits. This is the first part of our 3-part series featuring Dr....
08/04/2017
Cardiovascular Diseases
Cardiovascular Diseases
Charles Hennekens, MD, on the Safety of Statins for Patients With Diabetes
01/26/2017
Charles Hennekens, MD, talks about his study, "Statins and Diabetes: Current Perspectives and Implications for Clinicians," and whether statins are safe for patients with diabetes and other metabolic...
01/26/2017
Lipid & Metabolic
Lipid & Metabolic
Seth Martin, MD, on Making the Best Clinical Decision: Beyond the Friedewald Estimation
10/15/2018
In this podcast, Seth Martin, MD, from Johns Hopkins University School of Medicine, discusses his research on the direct method of estimating low-density lipoprotein cholesterol and how to better use this...
10/15/2018